Skip to main content
SpringerLink
Log in

Postmenopausal hormone therapy and risk of breast cancer by histologic type (United States)

  • Published:
Cancer Causes & Control Aims and scope Submit manuscript

Abstract

Objective: Postmenopausal hormone use and risk of breast cancer by histopathology was examined in a large multi-centered population-based case–control study. Methods: Women younger than 75 years newly diagnosed with invasive breast cancer between 1988 and 1991 were identified from statewide tumour registries in Wisconsin, Massachusetts, New Hampshire, and Maine. Only postmenopausal women were included in this analysis. Breast cancer cases (lobular (n = 219), ductal, NOS (n = 2172), and specific ductal subtypes (n = 242)) were compared with randomly selected population controls (n = 3179) using adjusted multi-variable polytomous logistic regression to estimate odds ratios (OR) and 95% confidence intervals (95%CI) for each histology. Results: Lobular carcinoma was associated with recent (within 2 years) estrogen therapy (OR:1.8, 95%CI: 1.0–3.4) and recent use of combined estrogen-plus-progestin therapy (OR:3.6, 95%CI: 1.8–7.6). Risk of ductal carcinoma was not associated with recent use of either estrogen alone (OR: 0.9, 95%CI: 0.7–1.2) or combined therapy (OR:0.9, 95%CI: 0.6–1.3). No associations were found with ductal subtypes. Conclusions: The association between postmenopausal hormone use and risk of breast cancer may depend on histopathology. Of particular interest is the association between combined hormone therapy and increased risk of lobular carcinoma. This lesion is increasingly common but, nonetheless, comprises fewer than 10% of invasive breast cancers.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Collaborative Group on Hormonal Factors in Breast Cancer(1997) Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52705 women with breast cancer and 108411 women without breast cancer. Lancet 350: 1047-1059.

    Google Scholar 

  2. Writing Group for the Women's Health Initiative Investigators(2002) Risks and benefits of estrogen-plus-progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 288: 321-333.

    Google Scholar 

  3. Li CI,Weiss NS,Stanford JL,Daling JR (2000) Hormone replacement therapy in relation to risk of lobular and ductal breast carcinoma in middle-aged women. Cancer 88: 2570-2577.

    Google Scholar 

  4. Chen C-L,Weiss NS,Newcomb P,Barlow W,White E (2002) Hormone replacement therapy in relation to breast cancer. JAMA 287: 734-741.

    Google Scholar 

  5. Newcomb PA,Titus-Ernstoff L,Egan KM, et al. (2002) Postmenopausal estrogen and progestin use in relation to breast cancer risk. Cancer Epi Biomark Prev 11: 593-600.

    Google Scholar 

  6. Newcomb PA,Longnecker MP,Storer BE, et al. (1995) Longterm hormone replacement therapy and risk of breast cancer in postmenopausal women. Am J Epidemiol 142: 788-795.

    Google Scholar 

  7. Newcomb PA,Storer BE,Longnecker MP, et al. (1994) Lactation and a reduced risk of premenopausal breast cancer. N Engl J Med 330: 81-87.

    Google Scholar 

  8. Percy C, Van Holten V, Muir C. International Classification of Diseases for Oncology, 2nd edn. Geneva, Switzerland, The World Health Organization.

  9. Hosmer Jr DW,Lemeshow S (1989) Applied Logistic Regression, New York: John Wiley &; Sons.

    Google Scholar 

  10. StataCorp(1997) Stata Statistical Software: Release 5.0. College Station, TX: Stata Corporation.

  11. Breslow NE,Day NE (1980) Statistical Methods in Cancer Research. Vol. 1. The Analysis of Case-control Studies. Lyon: IARC.

    Google Scholar 

  12. Berg JW,Hutter RV (1995) Breast cancer. Cancer 75: 257-269.

    Google Scholar 

  13. Stalsberg H,Thomas DB (1993) Age distribution of histologic types of breast carcinoma. Int J Cancer 54: 1-7.

    Google Scholar 

  14. LiVolsi VA,Kelsey JL,Fischer DB,Holford TR,Mostow ED,Goldenberg IS (1982) Effect of age at first childbirth on risk of developing specific histologic subtype of breast cancer. Cancer 49: 1937-1940.

    Google Scholar 

  15. Sloane JP,Amendoeira I,Apostolikas N, et al. (1999) Consistency achieved by 23 European pathologists from 12 countries in diagnosing breast disease and reporting prognostic features of carcinomas. European Commission Working Group on Breast Screening Pathology. Virchows Archiv 434: 3-10.

  16. Gapstur SM,Morrow M,Sellers TA (1999) Hormone replacement therapy and risk of breast cancer with a favorable histology: results of the Iowa Women's Health Study. J Natl Cancer Inst 281: 2091-2097.

    Google Scholar 

  17. Moorman PG,Newman B,Millikan RC,Tse C-KJ,Sandler DP (1999) Participation rates in a case-control study: the impact of age, race, and race of interviewer. Ann Epidemiol 9: 188-195.

    Google Scholar 

  18. Pike MC,Ross RK,Spicer DV (1998) Problems involved in including women with simple hysterectomy in epidemiologic studies measuring the effects of hormone replacement therapy on breast cancer risk. Am J Epidemiol 147: 718-721.

  19. Longnecker MP,Newcomb PA,Mittendorf R, et al (1992) The reliability of self-reported alcohol consumption in the remote past. Epidemiology 3: 535-539.

    Google Scholar 

  20. Paganini-Hill A,Ross RK (1982) Reliability of recall of drug usage and other health-related information. Am J Epidemiol 116: 114-122.

    Google Scholar 

  21. Persson I,Bergkvist L,Adami H (1987) Reliability of women's histories of climacteric oestrogen treatment assessed by prescription forms. Int J Epidemiol 16: 222-228.

    Google Scholar 

  22. Goodman MT,Nomura AMY,Wilkens LR,Kolonel LN (1990) Agreement between interview information and physician records on history of menopausal estrogen use. Am J Epidemiol 131: 815-825.

    Google Scholar 

  23. Barrett-Connor E (1991) Postmenopausal estrogen and prevention bias. Ann Intern Med 115: 455-456.

    Google Scholar 

  24. Colditz GA,Egan KM,Stampfer MJ (1993) Hormone replacement therapy and risk of breast cancer: results from epidemiologic studies. Am J Obstet Gynecol 168: 1473-1480.

    Google Scholar 

  25. Schairer C,Lubin J,Troisi R,Sturgeon S,Brinton L,Hoover R (2000) Menopausal estrogen and estrogen-progestin replacement therapy and breast cancer risk. JAMA 283: 485-491.

    Google Scholar 

  26. Tavassoli FA (1999) Pathology of the Breast, 2nd edn. Stamford, Connecticut: Appleton &; Lange.

    Google Scholar 

  27. Bassett LW,Jahan R,Fu YS (1997) Invasive malignancies. In: Bassett LW,Jackson VP,Jahan R,Fu YS,Gold RH, eds. Diagnosis of Diseases of the Breast. Philadelphia, Pennsylvania: W.B. Saunders Company, pp. 461-500.

    Google Scholar 

  28. Rosen PP (1997) Rosen's Breast Pathology. New York, NY: Lippincott-Raven Publishers.

    Google Scholar 

  29. Newcomer LM,Newcomb PA,Trentham-Dietz A, et al. (2002) Detection method and breast cancer histology. Cancer 95: 470-477.

    Google Scholar 

  30. Perez-Mesa CM (1995) Gross and microscopic pathology. In: Donegan WL, Spratt JS, eds. Cancer of the Breast, 4th edn. Philadelphia, Pennsylvania: W.B. Saunders Company, pp. 240-278.

    Google Scholar 

  31. Kaufman Z,Garstin WIH,Hayes R,Michell MJ,Baum M (1991) The mammographic parenchymal patterns of women on hormonal replacement therapy. Clin Radiol 43: 389-392.

    Google Scholar 

  32. Persson I,Thurfjell E,Holmberg L (1997) Effect of estrogen and estrogen-progestin replacement regimens on mammographic breast parenchymal density. J Clin Oncol 15: 3201-3207.

    Google Scholar 

  33. Laya MB,Gallagher JC,Schreiman JS,Larson EB,Watson P,Weinstein L (1995) Effect of postmenopausal hormonal replacement therapy on mammographic density and parenchymal pattern. Radiology 196: 433-437.

    Google Scholar 

  34. Li CI,Anderson BO,Porter P,Holt SK,Daling JR,Moe RE (2000) Changing incidence rate of invasive lobular breast carcinoma among older women. Cancer 88: 2561-2569.

    Google Scholar 

  35. Surveillance, Epidemiology, and End Results (SEER) Program Public-Use Data (1973-1999), National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch, released April 2002, based on the November 2001 submission.

Download references

Author information

Authors and Affiliations

  1. Fred Hutchinson Cancer Research Center, Seattle, WA, USA

    Laura M. Newcomer, Polly A. Newcomb, John D. Potter, Yutaka Yasui, Barry E. Storer & Janet R. Daling

  2. University of Wisconsin Comprehensive Cancer Center, Madison, WI, USA

    Polly A. Newcomb & Amy Trentham-Dietz

  3. Epidemiology Branch, National Institute of Environmental Health Sciences, Research Triangle Park, NC, USA

    Matthew P. Longnecker

  4. Norris Cotton Cancer Center, Dartmouth-Hitchcock Medical Center, Lebanon, NH, USA

    John A. Baron

Authors
  1. Laura M. Newcomer
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Polly A. Newcomb
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. John D. Potter
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Yutaka Yasui
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Amy Trentham-Dietz
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Barry E. Storer
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Matthew P. Longnecker
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. John A. Baron
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Janet R. Daling
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Newcomer, L.M., Newcomb, P.A., Potter, J.D. et al. Postmenopausal hormone therapy and risk of breast cancer by histologic type (United States). Cancer Causes Control 14, 225–233 (2003). https://doi.org/10.1023/A:1023634907723

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1023634907723

Search

Navigation